To keep drug prices high, pharma has been piling up the patents

To keep drug prices high, pharma has been piling up the patents

Add-on patents have increased drug patent periods from two years to over six.

arstechnica.com/health/2026/09/to-keep-drug-prices-high-pharma-has-been-piling-up-the-patents/